381 related articles for article (PubMed ID: 38037664)
1. Pharmacokinetics and tumor delivery of nanoparticles.
Yuan L; Chen Q; Riviere JE; Lin Z
J Drug Deliv Sci Technol; 2023 May; 83():. PubMed ID: 38037664
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of metallic nanoparticles.
Lin Z; Monteiro-Riviere NA; Riviere JE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):189-217. PubMed ID: 25316649
[TBL] [Abstract][Full Text] [Related]
3. Poly(Glycerol)-Based Biomedical Nanodevices Constructed by Functional Programming on Inorganic Nanoparticles for Cancer Nanomedicine.
Komatsu N
Acc Chem Res; 2023 Jan; 56(2):106-116. PubMed ID: 36602954
[TBL] [Abstract][Full Text] [Related]
4. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
5. Toxicological assessment of nanoparticle interactions with the pulmonary system.
Osman NM; Sexton DW; Saleem IY
Nanotoxicology; 2020 Feb; 14(1):21-58. PubMed ID: 31502904
[TBL] [Abstract][Full Text] [Related]
6. The stiffness-dependent tumor cell internalization of liquid metal nanoparticles.
He J; Pang W; Gu B; Lin X; Ye J
Nanoscale; 2022 Nov; 14(45):16902-16917. PubMed ID: 36342434
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
Ding XY; Hong CJ; Liu Y; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Zhang XN; Zhang Q
Int J Nanomedicine; 2012; 7():1723-35. PubMed ID: 22619523
[TBL] [Abstract][Full Text] [Related]
8. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic formulation of nanoparticles for biomedical applications.
Shepherd SJ; Issadore D; Mitchell MJ
Biomaterials; 2021 Jul; 274():120826. PubMed ID: 33965797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine.
Ravindran S; Suthar JK; Rokade R; Deshpande P; Singh P; Pratinidhi A; Khambadkhar R; Utekar S
Curr Drug Metab; 2018; 19(4):327-334. PubMed ID: 29512450
[TBL] [Abstract][Full Text] [Related]
11. Strategies to improve tumor penetration of nanomedicines through nanoparticle design.
Zhang YR; Lin R; Li HJ; He WL; Du JZ; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1519. PubMed ID: 29659166
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
13. Multistage Nanoparticle Delivery System-A New Approach to Cancer Therapeutics.
Li G; Chen L; Xin P; Huang J; Wu J
J Biomed Nanotechnol; 2020 Nov; 16(11):1570-1587. PubMed ID: 33461650
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery.
Dogra P; Butner JD; Ruiz RamÃrez J; Chuang YL; Noureddine A; Jeffrey Brinker C; Cristini V; Wang Z
Comput Struct Biotechnol J; 2020; 18():518-531. PubMed ID: 32206211
[TBL] [Abstract][Full Text] [Related]
15. A review on microfluidic-assisted nanoparticle synthesis, and their applications using multiscale simulation methods.
Agha A; Waheed W; Stiharu I; Nerguizian V; Destgeer G; Abu-Nada E; Alazzam A
Discov Nano; 2023 Feb; 18(1):18. PubMed ID: 36800044
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.
Kang H; Mintri S; Menon AV; Lee HY; Choi HS; Kim J
Nanoscale; 2015 Dec; 7(45):18848-62. PubMed ID: 26528835
[TBL] [Abstract][Full Text] [Related]
17. Nano-Cell Interactions of Non-Cationic Bionanomaterials.
Ho LWC; Liu Y; Han R; Bai Q; Choi CHJ
Acc Chem Res; 2019 Jun; 52(6):1519-1530. PubMed ID: 31058496
[TBL] [Abstract][Full Text] [Related]
18. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
19. Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting.
Mittelheisser V; Coliat P; Moeglin E; Goepp L; Goetz JG; Charbonnière LJ; Pivot X; Detappe A
Adv Mater; 2022 Jun; 34(24):e2110305. PubMed ID: 35289003
[TBL] [Abstract][Full Text] [Related]
20. Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration.
Kong SM; Costa DF; Jagielska A; Van Vliet KJ; Hammond PT
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34649991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
